19-Jan-2007 - Agilent Technologies Inc.

Agilent Technologies and Groton Biosystems Sign Co-Marketing Agreement for Pharmaceutical Manufacturing Solutions

Agilent Technologies Inc. and Groton Biosystems LLC announced an agreement to co-market solutions for the Process Analytical Technology (PAT) Initiative for the pharmaceutical industry in the United States and Canada.

PAT is a system for designing, analyzing and controlling manufacturing by measuring critical quality and performance attributes of raw and in-process materials and processes, all with the goal of ensuring final product quality.

The alliance is designed to benefit biopharmaceutical customers who perform in-process and final product testing in a wide range of production segments and who are looking for state-of-the-art online sampling with HPLC analysis for rapid quality-related decision-making.

The agreement, expected to expand to Europe and Asia in the near future, brings together Agilent's HPLC systems with Groton Biosystems' online sampling products and services.

Agilent Technologies Inc.

Recommend news PDF version / Print

Share on

Facts, background information, dossiers
  • Groton Biosystems
  • Agilent Technologies
  • services
More about Agilent